BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4216904)

  • 1. The action of ergot alkaloids (ergotamine and dihydroergotoxin) on the functional effects of cerebral ischemia in the cat.
    Boismare F; Streichenberger G
    Pharmacology; 1974; 12(3):152-9. PubMed ID: 4216904
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes induced with ergot alkaloids in the effects of cerebral ischemia on evoked potentials in the cat].
    Boismare F
    Atti Accad Med Lomb; 1972; 27(1-4):20-9. PubMed ID: 4377727
    [No Abstract]   [Full Text] [Related]  

  • 3. Vascular effects of dihydrogenated ergot alkaloids. Comparative effects of dihydroergostine and dihydroergotamine on the blood flow and the capacitance vessels in the human calf studied by plethysmography.
    Ulrich J; Siggaard-Andersen J
    Angiology; 1971 Dec; 22(11):622-8. PubMed ID: 5003295
    [No Abstract]   [Full Text] [Related]  

  • 4. [Action of some drugs used for cerebral vascular insufficiency on somesthesic primary potentials evoked at the level of cortex and thalamus in the cat in a state of acute cerebral ischemia].
    Rossignol P; Boulu R; Ribart M; Paultre C; Bache S; Truelle B
    C R Acad Hebd Seances Acad Sci D; 1972 May; 274(22):3027-9. PubMed ID: 4626346
    [No Abstract]   [Full Text] [Related]  

  • 5. Cerebral circulation. Effects of vasodilating drugs on blood flow and the microvasculature of ischemic and nonischemic cerebral cortex.
    Regli F; Yamaguchi T; Waltz AG
    Arch Neurol; 1971 May; 24(5):467-74. PubMed ID: 4995261
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of cerebral blood flow for the recovery of the brain after prolonged ischemia.
    Hossmann KA; Lechtape-Grüter H; Hossmann V
    Z Neurol; 1973; 204(4):281-99. PubMed ID: 4155720
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of ergot alkaloids (hydergine) on cerebral hemodynamics and oxygen consumption in monkeys.
    Szewczykowski J; Meyer JS; Kondo A; Nomura F; Teraura T
    J Neurol Sci; 1970 Jan; 10(1):25-31. PubMed ID: 4983718
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of so-called cerebral circulation or metabolism facilitating agents on cerebral function undergoing temporary anoxia--an experimental study in the isolated, perfused rat's brain model (author's transl)].
    Sumi Y; Yamada H; Sakai N; Tanabe Y; Hirata T
    No To Shinkei; 1980 Nov; 32(11):1109-16. PubMed ID: 6779841
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental study of the action of ergot hydrogenated derivates on neuroleptic-induced hypotension].
    Van den Driessche J; Eben Moussi E; Allain P
    Therapie; 1965; 20(3):655-68. PubMed ID: 4953938
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: Depression of the cortical evoked potential with reduction of local blood flow in baboons.
    Branston NM; Symon L
    J Physiol; 1974 Sep; 241(2):98P-99P. PubMed ID: 4443948
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of ergot alkaloids (Hydergine) on cerebral haemodynamics in man.
    Olesen J; Skinhej E
    Acta Pharmacol Toxicol (Copenh); 1972; 31(1):75-85. PubMed ID: 4623450
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of phosphodiesterase by dihydroergotamine and hydergine in various organs of the cat in vitro.
    Iwangoff R; Enz A
    Experientia; 1973 Sep; 29(9):1067-9. PubMed ID: 4355415
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacodynamics of the cerebral circulation. Angiographic study].
    Cappellini M; De Marzi S
    Nunt Radiol; 1967 Nov; 33(11):1343-62. PubMed ID: 4977950
    [No Abstract]   [Full Text] [Related]  

  • 14. [Alpha blocking properties of dihydro ergot derivatives. Regional sphygmographic finding].
    D'Ayala Valva G; Dabizzi RP; Banchelli A
    Riv Crit Clin Med; 1967 Aug; 67(3):177-90. PubMed ID: 4395432
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of hydergine on normal and pathological changes of blood flow in the cerebral cortex].
    Baldy-Moulinier M
    Pathol Biol; 1968; 16(15):759-64. PubMed ID: 4997339
    [No Abstract]   [Full Text] [Related]  

  • 16. The spinal cord processing of input from the superior sagittal sinus: pathway and modulation by ergot alkaloids.
    Lambert GA; Lowy AJ; Boers PM; Angus-Leppan H; Zagami AS
    Brain Res; 1992 Dec; 597(2):321-30. PubMed ID: 1473003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Action of hydrogenated ergot alkaloids upon transmission to sweat glands in the cat.
    Lloyd DP
    Proc Natl Acad Sci U S A; 1968 May; 60(1):115-7. PubMed ID: 4297914
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological aspects of dihydrogenated ergot alkaloids in experimental brain research.
    Meier-Ruge W; Emmenegger H; Enz A; Gygax P; Iwangoff P; Wiernsperger N
    Pharmacology; 1978; 16 Suppl 1():45-62. PubMed ID: 205890
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of dihydroergotoxine (Hydergine) and phenothiazines on conditioned avoidance reflexes and body temperature of the rat.
    Bálint G; Anokbonggo WW
    Acta Physiol Acad Sci Hung; 1968; 33(1):95-8. PubMed ID: 4968607
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug action on regional cerebral blood flow in cases of acute cerebro-vascular involvement.
    Agnoli A; Battistini N; Bozzao L; Fieschi C
    Acta Neurol Scand Suppl; 1965; 14():142-4. PubMed ID: 4284283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.